{"id":"https://openalex.org/W1885677122","doi":"https://doi.org/10.1200/jco.2001.19.5.1304","title":"Serum Prostate-Specific Antigen Decline as a Marker of Clinical Outcome in Hormone-Refractory Prostate Cancer Patients: Association With Progression-Free Survival, Pain End Points, and Survival","display_name":"Serum Prostate-Specific Antigen Decline as a Marker of Clinical Outcome in Hormone-Refractory Prostate Cancer Patients: Association With Progression-Free Survival, Pain End Points, and Survival","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1885677122","doi":"https://doi.org/10.1200/jco.2001.19.5.1304","mag":"1885677122","pmid":"https://pubmed.ncbi.nlm.nih.gov/11230472"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2001.19.5.1304","doi":"https://doi.org/10.1200/jco.2001.19.5.1304","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2001.19.5.1304","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J. Small","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112133128","display_name":"Alex McMillan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex McMillan","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007027978","display_name":"Mark Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Meyer","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100334627","display_name":"Liang Chen","orcid":"https://orcid.org/0000-0002-7985-4273","observed_orcids":["https://orcid.org/0000-0002-7985-4273"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Chen","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072632371","display_name":"William J. Slichenmyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J. Slichenmyer","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108528816","display_name":"Peter F. Lenehan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter F. Lenehan","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012074439","display_name":"Mario A. Eisenberger","orcid":"https://orcid.org/0000-0002-8787-3271","observed_orcids":["https://orcid.org/0000-0002-8787-3271"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Eisenberger","raw_affiliation_strings":["From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of California, San Francisco, CA; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI; and Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.1023,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.94782702,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"19","issue":"5","first_page":"1304","last_page":"1311"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.8109999895095825},{"id":"https://openalex.org/keywords/psa-decline","display_name":"PSA decline","score":0.8870000243186951},{"id":"https://openalex.org/keywords/suramin","display_name":"suramin","score":0.7559999823570251},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9959999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7710000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8059999942779541},{"id":"https://openalex.org/keywords/intermediate-endpoints","display_name":"intermediate endpoints","score":0.5600000023841858},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.6389999985694885},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8627941608428955},{"id":"https://openalex.org/C2776182878","wikidata":"https://www.wikidata.org/wiki/Q425946","display_name":"Suramin","level":3,"score":0.8410699367523193},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6625681519508362},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.608644962310791},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.5866544246673584},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5198779106140137},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.49142658710479736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4870441257953644},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.4832623600959778},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.42781850695610046},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4212314188480377},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4170338213443756},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.41188639402389526},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35297638177871704},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3343903422355652},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3325813412666321},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.26354795694351196},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13859400153160095},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013498","descriptor_name":"Suramin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2001.19.5.1304","doi":"https://doi.org/10.1200/jco.2001.19.5.1304","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2001.19.5.1304","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:11230472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11230472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1797512951","https://openalex.org/W1854708637","https://openalex.org/W1884665868","https://openalex.org/W1893347245","https://openalex.org/W1907260682","https://openalex.org/W2069552038","https://openalex.org/W2117399653","https://openalex.org/W2120079339","https://openalex.org/W2121146904","https://openalex.org/W2129630152","https://openalex.org/W2142365214","https://openalex.org/W2151232297","https://openalex.org/W2155949904","https://openalex.org/W2160064859","https://openalex.org/W2165631552","https://openalex.org/W2171724045","https://openalex.org/W2173354177","https://openalex.org/W2258963766","https://openalex.org/W2320909684","https://openalex.org/W3041047318","https://openalex.org/W3147894994","https://openalex.org/W4239330499","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2125942853","https://openalex.org/W2258963766","https://openalex.org/W2117399653","https://openalex.org/W2249444889","https://openalex.org/W7097119079","https://openalex.org/W2011580644","https://openalex.org/W2121847561","https://openalex.org/W2100858556","https://openalex.org/W2479830235","https://openalex.org/W44607965"],"abstract_inverted_index":{"PURPOSE:":[0],"Validated":[1],"end":[2,97,165,271],"points":[3,98],"are":[4],"lacking":[5],"for":[6],"clinical":[7,43,164,281],"trials":[8,275],"in":[9,38,47,170,196,210,233,264,273,288],"hormone-refractory":[10],"prostate":[11],"cancer":[12],"(HRPC).":[13],"Controversy":[14],"remains":[15],"regarding":[16],"the":[17,155,197,201,280,287],"utility":[18,282],"of":[19,23,29,45,53,66,115,124,128,154,157,172,222,235,283,291],"a":[20,48,122,125,142,187,230,261,268],"posttreatment":[21,36,262],"decline":[22,127,159,169,232,263],"prostate-specific":[24],"antigen":[25],"(PSA).":[26],"The":[27],"purpose":[28],"this":[30,218],"study":[31],"was":[32,138,160,183,243],"to":[33,72,109],"determine":[34],"whether":[35],"declines":[37],"PSA":[39,126,158,171,234,265,295],"were":[40,70],"associated":[41,185,244],"with":[42,186,245],"measures":[44],"improvement":[46],"randomized":[49,71,220],"phase":[50],"III":[51],"trial":[52,221],"suramin":[54,74,202,223],"plus":[55,59,75,82,203,224,228],"hydrocortisone":[56,76,83,204,225],"versus":[57,226],"placebo":[58,81,227],"hydrocortisone.":[60],"PATIENTS":[61],"AND":[62],"METHODS:":[63],"A":[64,151,168],"total":[65],"460":[67],"HRPC":[68,92,274],"patients":[69,88],"receive":[73],"(n":[77,84],"=":[78,85,131,175,180,238],"229)":[79],"or":[80,130,174,179,237],"231).":[86],"All":[87],"had":[89],"symptomatic,":[90],"metastatic":[91],"requiring":[93],"opioid":[94],"analgesics.":[95],"Clinical":[96],"evaluated":[99],"included":[100],"overall":[101,116,190,248],"survival,":[102,117,191,249,253],"objective":[103],"progression-free":[104,252],"survival":[105],"(OPFS),":[106],"and":[107,119,148,193,200,213,254,276],"time":[108],"pain":[110],"progression":[111],"(TTPP).":[112],"An":[113],"evaluation":[114],"OPFS,":[118,192],"TTPP":[120],"as":[121],"function":[123],">":[129,173,178,236],"50%,":[132,239],"lasting":[133,177,240],"at":[134,145,206],"least":[135],"28":[136,181,241],"days,":[137,242],"undertaken":[139],"by":[140],"using":[141],"landmark":[143],"analysis":[144,153,258],"6,":[146],"9,":[147],"12":[149],"weeks.":[150],"multivariate":[152,214],"impact":[156],"performed":[161],"on":[162,294],"these":[163],"points.":[166],"RESULTS:":[167],"50%":[176],"days":[182],"significantly":[184],"prolonged":[188,246],"median":[189,247,251,255],"TTPP,":[194],"both":[195,211],"entire":[198],"group":[199,205],"all":[207],"three":[208],"landmarks":[209],"univariate":[212],"analysis.":[215],"CONCLUSION:":[216],"In":[217],"prospective,":[219],"hydrocortisone,":[229],"posttherapy":[231],"improved":[250],"TTPP.":[256],"This":[257],"suggests":[259],"that":[260],"may":[266],"be":[267],"reasonable":[269],"intermediate":[270],"point":[272],"calls":[277],"into":[278],"question":[279],"preclinical":[284],"assays":[285],"evaluating":[286],"vitro":[289],"effect":[290],"given":[292],"agents":[293],"secretion.":[296]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}